(The Hill) — The drugmaker Eli Lilly is cutting prices for its insulin and capping costs at $35 per month, the company said Wednesday.
Out-of-pocket costs at participating retail pharmacies will max out at $35 for patients with commercial insurance using Lilly insulin, according to a release. People without insurance can still benefit if they use Lilly’s savings card program.
The cap is an immediate change that comes as the company works to reduce the prices of its most commonly prescribed insulin, Humalog and Humulin, by 70 percent. Lilly’s Chair and CEO David Ricks said the change “will take time for the insurance and pharmacy system to implement.”
thehill.com/policy/healthcare/3878934-eli-lilly-caps-insulin-costs-at-35-per-month/
Views: